Adipocyte-released insulin-like growth factor-1 is regulated by glucose and fatty acids and controls breast cancer cell growth in vitro
Open Access
- 15 July 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Diabetologia
- Vol. 55 (10), 2811-2822
- https://doi.org/10.1007/s00125-012-2629-7
Abstract
Type 2 diabetes and obesity are associated with increased risk of site-specific cancers. We have investigated whether metabolic alterations at the level of adipose-derived differentiating cells may affect specific phenotypes of breast cancer cells.This publication has 50 references indexed in Scilit:
- Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and ProgressionEndocrine Reviews, 2011
- Selective Disruption of Insulin-like Growth Factor-1 (IGF-1) Signaling via Phosphoinositide-dependent Kinase-1 Prevents the Protective Effect of IGF-1 on Human Cancer Cell DeathOnline Journal of Public Health Informatics, 2010
- Obesity and Breast Cancer: The Estrogen ConnectionEndocrinology, 2009
- Many cytokines are very useful therapeutic targets in diseaseJCI Insight, 2008
- Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetesNature Reviews Molecular Cell Biology, 2008
- Role of chemokines in tumor growthCancer Letters, 2007
- Overweight, obesity and cancer: epidemiological evidence and proposed mechanismsNature Reviews Cancer, 2004
- Insulin-like growth factors and neoplasiaNature Reviews Cancer, 2004
- Circulating concentrations of insulin-like growth factor I and risk of breast cancerThe Lancet, 1998
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI Journal of the National Cancer Institute, 1990